High-Tech Gründerfonds

High-Tech Gruenderfonds invests in young, high potential high-tech start-ups. The seed financing provided is designed to enable start-ups to take an idea through prototyping and to market launch. Typically, High-Tech Gruenderfonds invests EUR 500,000 in the seed stage, with the potential for up to a total of EUR 2 million per portfolio company in follow-on financing. Investors in this public/private partnership include the Federal Ministry of Economics and Energy, the KfW Banking Group, as well as strategic corporate investors including ALTANA, BASF, Bayer, B. Braun, Robert Bosch, CEWE, Daimler, Deutsche Post DHL, Deutsche Telekom, Evonik, Lanxess, media + more venture Beteiligungs GmbH & Co. KG, METRO, Qiagen, RWE Innogy, SAP, Tengelmann and Carl Zeiss. High-Tech Gruenderfonds has about EUR 576 million under management in two funds (EUR 272 million HTGF I, EUR 304 million HTGF II).

Helmut Ponath

Helmut Ponath, CEO and Executive Spokesman for the Reederei NSB, is an experienced, extraordinarily successful Business Angel who is active in a variety of business fields with tremendous economic potential.

Hubertus Wald Stiftung

Hubertus Wald and his wife Renate are among the most generous and important patrons in Hamburg. For many years now the Hubertus Wald Stiftung, which they endowed, has promoted and financed important work in the areas of medical research, culture, and social projects primarily in Hamburg.

Through its investment in Immunservice GmbH, the Hubertus Wald Stiftung is combining two central foundation functions: the promotion of medical innovation and the long-term mission of increasing the foundation’s endowment.

Dr. Michael Otto

Dr. Michael Otto is Chairman of the Board at the Otto Group, an international trading and services corporation, and one of Germany’s most successful entrepreneurs. Besides his tremendous engagement for sustainability in business, he also keeps a keen eye on innovative technologies. This has made the Otto Group one of Germany’s largest corporate venture investors in start-ups. Dr. Michael Otto also invests privately  in innovative firms.